Two separate studies have shown that the efficacy of Bavarian Nordic’s vaccine against the deadly infectious disease wanes ...

Journey through the scientific breakthroughs that have revolutionized our understanding of the universe, life, and everything in between.

Medical science has made astounding breakthroughs over the past century. With the advent of AI and quantum computing, there’s ...

Unlike the millions of dollars that poured into Congo for Ebola and COVID aid, the response to mpox has been sluggish, many ...

The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.

Youngsters have been especially impacted by mpox outbreaks raging in Africa, with children under five accounting for nearly a ...

The Africa Centres for Disease Control and Prevention (Africa CDC) has raised concerns that the Mpox outbreak in Africa ...

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

Health authorities have struggled to contain outbreaks of mpox in Congo, a huge central African country where a myriad of ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

With concerns that mpox may now spread more easily and be more severe, researchers warn that failing to curb the outbreak means “nobody is safe.” ...